» Articles » PMID: 15279562

Structure and Mechanism of Monoamine Oxidase

Overview
Journal Curr Med Chem
Specialty Chemistry
Date 2004 Jul 29
PMID 15279562
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Monoamine oxidases A and B (MAO A and MAO B) are mitochondrial outer membrane-bound flavoproteins that catalyze the oxidative deamination of neurotransmitters and biogenic amines. A number of mechanism-based inhibitors (MAOI's) have been developed for clinical use as antidepressants and as neuroprotective drugs. To facilitate the development of more effective and specific inhibitors, a detailed understanding of the structures and catalytic mechanisms of these enzymes is required. The recent development of high level expression systems for producing recombinant human liver MAO A and MAO B in Pichia pastoris has facilitated the determination of the three dimensional crystal structures of MAO B (up to 1.7 angstroms resolution) in complex with different reversible (isatin, 1,4-diphenyl-2-butene) and irreversible inhibitors (pargyline, N-(2-aminoethyl)-p-chlorobenzamide, and trans-2-phenylcyclopropylamine). The binding of substrates or inhibitors to MAO B involves an initial negotiation of a protein loop occurring near the surface of the membrane and two hydrophobic cavities; an "entrance" cavity and an "active site" cavity. These two cavities can either be separate or in a fused state depending on the conformation of the Ile199 side chain, which appears to function as a gate. The amine function of the bound substrate approaches the re face of the bent and "puckered" covalent FAD through an "aromatic cage" formed by two tyrosine residues that are perpendicular to the plane of the flavin ring. No amino acid residues that could function as acids or bases are found near the catalytic site. The existing structural data on MAO B support previous QSAR results and are also supportive of a proposed polar nucleophilic mechanism for MAO A and B catalysis rather than the alternatively proposed single electron transfer mechanism.

Citing Articles

Polyextremotolerant, opportunistic, and melanin-driven resilient black yeast Exophiala dermatitidis in environmental and clinical contexts.

de Leon L, Moreno-Perlin T, Castillo-Marenco T, Del Rayo Sanchez-Carbente M, Gostincar C, Ramirez-Duran N Sci Rep. 2025; 15(1):6472.

PMID: 39987208 PMC: 11846982. DOI: 10.1038/s41598-025-88595-z.


Purified Pigments: Biological Activities and Mechanisms of Action.

Husakova M, Patakova P J Nat Prod. 2025; 88(2):607-615.

PMID: 39906945 PMC: 11877510. DOI: 10.1021/acs.jnatprod.4c01008.


Neurotoxicology of dopamine: Victim or assailant?.

Bucher M, Dicent J, Hospital C, Miller G Neurotoxicology. 2024; 103:175-188.

PMID: 38857676 PMC: 11694735. DOI: 10.1016/j.neuro.2024.06.001.


Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer's Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy.

Sheng L, Bhalla R Neurochem Res. 2024; 49(9):2273-2302.

PMID: 38844706 PMC: 11310295. DOI: 10.1007/s11064-024-04178-w.


Dysregulation of platelet serotonin, 14-3-3, and GPIX in sudden infant death syndrome.

Frelinger 3rd A, Haynes R, Goldstein R, Berny-Lang M, Gerrits A, Riehs M Sci Rep. 2024; 14(1):11092.

PMID: 38750089 PMC: 11096399. DOI: 10.1038/s41598-024-61949-9.